Biogen Idec Buys Stromedix, Bringing IPF Candidate Full Circle
This article was originally published in The Pink Sheet Daily
Executive Summary
Started by a former Biogen executive, Stromedix licensed STX-100 from Biogen and developed it into an attractive candidate in an area the reshaped big biotech wants to pursue.